Dr. Reddy’s Laboratories Ltd.
Company Snapshot
Company Overview
Dr. Reddy’s is a pharmaceutical company with products ranging from generics, over-the-counters medicines, and APIs to biologics and proprietary products. The company’s Custom Pharma Services (CPS) business unit provides third parties with pharmaceutical development and manufacturing services and solutions for starting materials, intermediates, active ingredients, and finished dosage forms. The therapeutic areas where Dr. Reddy’s focuses include oncology, gastroenterology, cardiovascular, diabetes, and pain management. Dr. Reddy’s has 22 manufacturing sites and eight R&D facilities across the globe. Aurigene Oncology Ltd., a wholly owned subsidiary of Dr. Reddy’s, is working on chimeric antigen receptor (CAR) T-cell therapy for oncology in India.
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Dr. Reddy’s Laboratories Ltd. In Reports
Dr. Reddy’s Laboratories Ltd. In News
Company's Business Segments
- Global Generics : Branded and unbranded prescription medicine, Over The Counter (otc) Pharmaceutical products, Biosimilars business
- Pharmaceutical Services and Active Ingredients (PSAI) : Active Pharmaceutical Ingredients (APIs), Aurigene Pharmaceutical Services (APSL)
Applications/End User Industries
- Research and Development
- Manufacturing and Supply Chain
- Digitalisation